Arbutus Biopharma Corporation
Arbutus Biopharma Corporation
ABUS
Valuace
70
Růst
38
Zdraví
75
Cena
$ 4.59
Dnes
--0.64 (-13.62%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.9B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-55%
ROA
-43%
PE
-24
PS
58
Cena 1R
3-5
⌀ Cena
3.88
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
26-03-2026
Poslední dividenda

Profil

Biofarmaceutická společnost Arbutus Biopharma Corporation vyvíjí ve Spojených státech nové způsoby léčby chronické infekce virem hepatitidy B (HBV), SARS-CoV-2 a dalších koronavirů. Jeho produktový kanál HBV se skládá z AB-729, patentovaného subkutánně dodávaného RNA interferenčního přípravku, který se v klinické studii fáze Ia/Ib zaměřoval na hepatocyty, které inhibují replikaci viru a redukují různé HBV antigeny pomocí nové kovalentně konjugované N-acetylgalaktosamin (GalNAc) aplikační technologie, a AB-836, perorálního kapsidového inhibitoru, který potlačuje replikaci HBV DNA. Výzkumné a vývojové programy společnosti zahrnují AB-161, perorální destabilizátor HBV RNA k destabilizaci HBV RNA, což vede ke snížení HBsAg a dalších virových proteinů; AB-101, perorální PD-L1 inhibitor k opětovnému probuzení HBV-specifické imunitní odpovědi pacientů; a malé molekuly antivirotik k léčbě koronavirů, včetně COVID-19. Má strategické aliance, licence a dohody o výzkumné spolupráci s Talon Therapeutics, Inc.; Gritstone Oncology, Inc.; Alnylam Pharmaceuticals, Inc.; Qilu Pharmaceuticals Co, Ltd.; Assembly Biosciences, Inc.; Acuitas Therapeutics, Inc.; a Antios Therapeutics, Inc. Arbutus Biopharma Corporation má také dohodu o klinické spolupráci s Vaccitech plc vyhodnotit trojkombinaci AB-729 pro léčbu chronické infekce HBV. Společnost byla dříve známá jako Tekmira Pharmaceuticals Corporation a v červenci 2015 změnila svůj název na Arbutus Biopharma Corporation. Arbutus Biopharma Corporation má sídlo ve Warminsteru v Pensylvánii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
44
Založení
2007-07-26
Adresa
701 Veterans Circle
CEO
Lindsay Androski

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues14.114.16.218.139.011.06.96.05.910.71.524.915.015.514.216.321.4
Cost of Revenues9.00.40.073.70.00.047.557.657.962.761.351.538.721.518.119.522.1
Gross Profit5.113.76.2-55.639.011.0-40.6-51.6-52.0-52.0-59.8-26.6-23.7-6.0-3.9-3.2-0.8
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues1.10.510.71.81.61.31.71.52.14.7
Cost of Revenues0.00.00.09.08.80.00.00.00.40.4
Gross Profit1.00.510.7-7.2-7.21.31.71.51.84.3
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.073.784.465.547.557.657.962.761.351.538.721.518.10.022,133,983.0
Selling General & Admin Expenses0.00.00.022.517.817.114.717.716.016.139.426.48.75.526.96.24.8
Depreciation & Amortization0.40.41.41.44.42.00.754.52.22.01.10.60.50.60.91.01.0
Total Operating Expenses54.240.882.596.2102.282.664.277.476.180.8101.878.547.927.6-19.57.111.7
Operating Income-27.1-27.1-76.3-78.1-65.5-73.5-57.8-144.1-89.8-110.9-491.6-102.3-33.0-12.2-13.0-10.3-12.5
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.017.620.2
Selling General & Admin Expenses0.00.00.00.00.00.00.00.04.75.8
Depreciation & Amortization0.00.00.00.30.30.30.40.40.40.4
Total Operating Expenses8.78.89.327.56.722.823.320.922.326.2
Operating Income14.4-8.31.5-34.7-13.9-21.4-21.6-19.4-20.5-21.6
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income4.14.16.65.72.20.10.72.13.01.51.40.70.90.50.10.10.1
Interest Expense0.10.10.10.51.72.94.02.10.20.31.40.70.90.50.10.10.1
Other Expense-6.5-6.56.45.30.4-2.7-5.9-22.36.0-38.6-388.8-24.3-5.8-2.5-3.80.50.0
IBT-33.5-33.5-69.9-72.8-65.0-76.2-63.7-166.4-61.4-108.7-489.1-77.3-38.7-14.129.9-9,937.0-12.5
Income Tax Expense0.00.00.00.04.41.11.5-12.7-4.3-24.3-105.0-16.20.11.93.7-0.6-0.1
Net Income-33.5-33.5-69.9-72.8-69.5-77.4-65.2-153.7-57.1-84.4-384.1-61.1-38.8-14.129.9-9.7-12.4
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.91.01.01.21.51.71.81.51.51.5
Interest Expense0.00.00.00.00.00.00.00.00.00.0
Other Expense-18.20.61.010.11.41.71.81.51.41.5
IBT-3.8-7.72.5-24.5-12.5-19.7-19.8-17.9-19.3-20.1
Income Tax Expense0.00.00.00.00.00.00.00.01.1-0.4
Net Income-3.8-7.72.5-24.5-12.5-19.7-19.8-17.9-19.3-20.1
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-0.44$-0.46$-0.73$-0.86$-2.69$-1.03$-1.54$-7.24$-1.34$-1.73$-0.92$2.16$-0.86$-1.20
EPS Diluted$0.00$0.00$0.00$-0.44$-0.46$-0.73$-0.86$-2.69$-1.03$-1.54$-7.24$-1.34$-1.73$-0.92$2.07$-0.86$-1.20
Shares Outstanding191.6191.6185.6166.0150.9106.275.857.155.354.753.145.522.415.313.711.310.3
Diluted Shares Outstanding191.6191.6185.6166.0150.9106.275.857.155.354.753.145.522.415.314.311.310.3
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.11$-0.12
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.11$-0.12
Shares Outstanding191.6191.8191.6190.7185.6189.0188.0175.6168.4167.5
Diluted Shares Outstanding191.6191.8192.4190.7190.0189.0188.0175.6168.4167.5
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents62.836.326.330.8109.352.331.836.954.323.4166.872.268.747.09.012.3
Short Term Investments79.286.399.7116.146.071.059.087.772.1107.114.540.00.00.00.00.0
Total Cash & ST Investments142.0122.6126.0146.9155.3123.390.8124.6126.4130.5181.3112.268.747.09.012.3
Accounts Receivable2.12.41.84.25.34.41.21.40.40.31.41.90.43.51.43.7
Inventory-6.20.00.0-2.9-4.4-3.10.00.00.00.01.10.01.0-2.00.00.2
Other Current Assets4.22.34.22.94.43.11.83.22.61.80.12.30.22.81.20.8
Total Current Assets148.2127.3132.0151.1160.7127.793.8129.2129.4132.6183.9116.470.351.211.617.9
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents22.437.437.136.331.862.843.126.317.527.2
Short Term Investments71.360.775.686.395.979.286.199.7116.6125.3
Total Cash & ST Investments93.798.1112.7122.6127.8142.0129.2126.0134.2152.5
Accounts Receivable0.91.01.22.41.62.12.11.82.22.6
Inventory0.00.00.00.00.00.00.00.0-5.3-2.6
Other Current Assets2.84.02.92.33.44.24.53.65.33.7
Total Current Assets97.4103.1116.8127.3132.8148.2135.9132.0141.6158.8
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment5.34.46.16.88.19.311.410.212.26.93.21.81.41.42.23.1
Goodwill0.00.00.00.00.00.00.022.524.424.4162.50.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.043.858.699.4352.60.00.00.00.00.0
Long-Term Investments6.50.06.337.435.70.00.022.20.00.010.10.00.00.00.00.0
Other Long-Term Assets0.00.00.00.10.10.00.322.212.612.60.00.00.00.00.00.0
Total Long-Term Assets11.84.412.444.343.89.411.798.7107.8143.3528.41.81.41.42.23.1
Total Assets160.0131.7144.4195.4204.5137.1105.5227.9237.2275.9712.3118.271.752.613.721.0
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment0.10.10.24.44.75.35.76.16.57.0
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.0
Long-Term Investments0.00.00.00.03.06.58.76.310.511.1
Other Long-Term Assets0.10.00.00.00.00.00.00.00.00.0
Total Long-Term Assets0.30.10.24.47.711.814.412.417.018.0
Total Assets97.7103.3117.0131.7140.4160.0150.3144.4158.6176.8
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable2.72.33.23.53.23.02.43.22.03.22.62.01.20.80.00.0
Short-Term Debt0.50.50.90.40.40.40.30.06.06.76.21.52.53.00.00.0
Other Current Liabilities8.55.29.912.50.00.30.36.81.20.70.95.15.44.04.16.2
Current Liabilities22.615.622.532.911.29.57.810.011.910.610.614.412.511.06.88.1
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable0.01.30.02.32.32.73.73.22.31.0
Short-Term Debt0.50.50.60.50.50.50.50.90.80.8
Other Current Liabilities4.73.212.15.216.18.516.19.911.612.0
Current Liabilities5.25.019.415.618.922.620.322.522.324.5
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt5.90.88.31.82.22.63.00.012.012.00.00.00.00.00.00.0
Capital Leases1.11.31.82.22.63.03.40.00.00.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.0-19.012.716.941.2146.30.00.00.00.00.0
Total Liabilities37.634.338.458.635.035.132.827.754.772.9164.630.212.511.78.510.3
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt0.44.50.60.86.37.07.68.31.51.6
Capital Leases0.91.11.21.31.41.11.71.31.92.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities20.320.337.934.333.637.635.738.439.342.1
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock1,403.31,410.01,349.81,318.71,286.6985.9898.5879.4876.1867.4834.2290.0216.7239.510,333.010,333.0
Retained Earnings-1,314.3-1,346.6-1,276.7-1,203.8-1,134.3-1,046.0-970.1-805.2-738.1-651.1-267.0-205.9-167.0-230.2-253.5-248.9
Comprehensive Income-48.3-48.1-48.4-50.5-48.3-48.2-48.2-48.2-48.2-49.8-49.8-22.3-15.8-13.0-16.1-15.6
Total Common Equity122.597.4106.0136.9169.4102.072.7200.2182.5203.0547.788.059.240.95.210.7
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.01,417.10.01,410.01,407.61,403.31,377.31,349.81,346.01,344.2
Retained Earnings0.0-1,368.60.0-1,346.6-1,334.0-1,314.3-1,294.5-1,276.7-1,257.3-1,237.2
Comprehensive Income-48.1-48.2-48.2-48.1-48.1-48.3-48.4-48.4-48.9-49.5
Total Common Equity77.483.079.297.4106.9122.5114.6106.0119.3134.7
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt7.51.38.72.22.63.03.40.012.012.00.00.00.00.00.00.0
Book Value122.597.4106.0136.9169.4102.072.7200.2182.5203.0547.788.059.240.95.210.7
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value77.483.079.297.4106.9122.5114.6106.0119.3134.7
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-77.1-33.5-69.9-72.8-69.5-76.2-63.7-153.7-57.1-84.4-384.2-61.1-38.8-14.129.9-9.7-12.4
Depreciation & Amortization1.40.41.41.41.41.82.02.02.22.01.10.60.50.60.91.01.0
Stock-Based Compensation9.47.09.09.37.26.46.26.86.215.139.222.13.30.91.00.60.7
Change Working Capital-1.7-10.0-2.8-18.229.20.90.4-2.2-4.33.1-0.5-14.616.52.3-2.41.1-0.5
Change In Accounts Receivable0.91.4-0.6-0.4-0.50.4-0.10.2-1.0-0.10.70.6-1.90.9-0.22.4-2.3
Change In Accounts Payable2.4-2.10.0-5.85.21.91.7-2.4-1.30.70.0-2.56.30.1-0.2-2,179,372.0498,096.0
Change In Inventories-1.00.00.06.20.0-1.90.00.00.8-0.9-0.20.3-1.21.2-1.80.1-0.2
Other Non-cash Items4.4-3.4-2.5-5.6-3.87.89.388.8-10.739.8391.614.510.43.50.0-10.30.7
Cash from Operations-71.60.00.0-85.9-35.4-67.5-51.4-71.0-67.9-48.6-57.9-54.8-12.4-6.733.3-7.5-11.2
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-3.8-7.72.5-24.5-12.5-19.7-19.8-17.9-19.3-20.1
Depreciation & Amortization1.00.00.00.30.30.30.40.40.40.4
Stock-Based Compensation14.91.30.93.61.62.23.22.01.72.5
Change Working Capital2.01.2-18.25.3-0.2-2.52.8-2.91.7-3.4
Change In Accounts Receivable-0.10.10.21.2-0.80.20.4-0.40.40.4
Change In Accounts Payable0.80.00.04.50.00.00.0-2.00.51.0
Change In Inventories0.00.00.00.00.00.00.00.00.0-1.0
Other Non-cash Items-18.9-0.5-0.92.00.5-1.0-1.0-0.90.8-0.5
Cash from Operations0.00.00.00.00.00.00.00.0-16.2-21.8
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-0.10.0-0.2-1.0-0.5-0.8-0.2-0.6-1.1-7.3-4.0-2.3-1.1-0.70.0-0.1-0.8
Acquisitions37.20.00.00.00.51.8-2.50.00.00.00.00.30.00.00.00.00.0
Investments-87.712.9-141.5-80.5-130.4-82.2-85.6-58.80.00.0-95.20.0-42.00.00.00.00.0
Sales of Investment141.2155.3164.6132.356.070.473.487.70.00.00.00.00.00.00.00.00.0
Other Investing Activities10.20.00.00.0-0.5-1.80.00.0-3.035.10.09.60.10.00.00.00.0
Cash from Investing53.40.00.050.8-74.9-12.7-14.928.3-4.127.8-99.17.7-43.0-0.70.0-0.1-0.8
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.00.00.00.0-0.10.00.0-0.10.00.0
Acquisitions0.00.00.00.00.00.00.037.20.00.0
Investments-158.5-51.3-28.5-34.7-43.2-40.3-32.6-25.4-23.1-7.1
Sales of Investment0.041.344.146.156.728.442.437.244.717.5
Other Investing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Investing0.00.00.00.00.00.00.00.021.610.4
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid0.00.00.00.00.00.00.00.0-12.00.00.00.00.00.00.00.00.0
Debt Issued5.41.3-7.46.5-0.4-0.4-0.43.40.012.012.00.00.00.00.00.00.0
Issuance of Common Stock53.30.00.029.931.3134.786.318.60.00.00.0142.256.532.03.94.50.0
Repurchase of Common Stock0.00.00.00.011.00.00.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.0-12.1-12.1-11.1-10.10.00.00.00.00.00.00.00.0
Other Financing Activities52.90.00.00.8-10.514.712.630.077.749.312.61.74.20.70.70.00.0
Cash from Financing53.60.00.030.631.8137.286.737.555.649.312.6143.960.732.74.64.50.0
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued0.9-4.13.8-0.1-5.5-0.7-0.6-0.66.8-0.1
Issuance of Common Stock0.00.00.00.00.00.00.00.03.91.4
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.00.3
Cash from Financing0.00.00.00.00.00.00.00.03.41.7
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash35.6-18.310.0-4.5-78.557.020.5-5.1-17.430.9-143.494.63.521.737.8-3.1-12.0
Closing Cash Balance62.818.036.326.330.8109.352.331.836.954.323.4166.872.268.747.09.012.3
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-4.4-15.00.30.74.5-30.919.716.88.8-9.7
Closing Cash Balance18.022.437.437.136.331.862.843.126.317.5
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-71.7-39.6-65.0-86.9-35.9-68.3-51.7-71.6-69.0-55.9-61.9-57.1-13.5-7.533.3-7.6-12.1
Real Free Cash Flow-81.1-46.6-74.0-96.2-43.1-74.8-57.8-78.4-75.3-71.0-101.0-79.2-16.8-8.432.3-8.2-12.7
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-4.7-5.8-15.7-13.4-10.4-20.7-14.5-19.4-16.2-21.8
Real Free Cash Flow-19.6-7.1-16.6-17.0-12.0-22.9-17.7-21.4-17.9-24.3
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-24.2-5-1.4
P/S57.741.39.4
P/B10.52.85.2
P/FCF-13.5-5.3-1.5
Market cap$0.9$0.9
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0.9 %1.4 %0 %
Debt to Income-2.8 %-2.3 %0 %
Debt to Free cash flow-1.5 %-1673.7 %0 %
Interest expense percentage-0.4 %-1.8 %44.7 %
Current ratio18.8 9.1 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-43.3 %-121 %0 %
ROA-34.3 %-45 %0 %
CapEx to Revenue0.5 %32 %0 %
RaD to Revenue0 %15734225.1 %0 %
ROEM320,068.2 311163.3

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin-21.7 %-300729.9 %68.7 %
Operating margin-379.3 %-2180.9 %35.5 %
Net margin-289.4 %-1785.1 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %1.7 %0 %
Dividend payout percentage0 %-4.1 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding191.8 mil 72.1 mil
Employee count0.0 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader